Varian Medical Systems, Inc. (VAR) Shares Sold by Ancora Advisors LLC

Share on StockTwits

Ancora Advisors LLC cut its stake in Varian Medical Systems, Inc. (NYSE:VAR) by 1.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 77,025 shares of the medical equipment provider’s stock after selling 962 shares during the period. Ancora Advisors LLC owned 0.08% of Varian Medical Systems worth $8,728,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in VAR. Pearl River Capital LLC bought a new position in shares of Varian Medical Systems in the fourth quarter worth about $28,000. First Personal Financial Services raised its stake in shares of Varian Medical Systems by 58.8% in the fourth quarter. First Personal Financial Services now owns 351 shares of the medical equipment provider’s stock worth $40,000 after acquiring an additional 130 shares during the last quarter. Moody National Bank Trust Division bought a new position in shares of Varian Medical Systems in the fourth quarter worth about $49,000. Financial Gravity Companies Inc. bought a new position in shares of Varian Medical Systems in the fourth quarter worth about $49,000. Finally, Enlightenment Research LLC bought a new position in shares of Varian Medical Systems in the fourth quarter worth about $57,000. 91.66% of the stock is owned by institutional investors.

In related news, Director R Andrew Eckert sold 5,651 shares of the business’s stock in a transaction that occurred on Monday, January 28th. The shares were sold at an average price of $130.15, for a total transaction of $735,477.65. Following the completion of the sale, the director now directly owns 9,806 shares of the company’s stock, valued at $1,276,250.90. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Kolleen T. Kennedy sold 19,580 shares of the company’s stock in a transaction that occurred on Monday, January 28th. The shares were sold at an average price of $130.48, for a total transaction of $2,554,798.40. Following the completion of the sale, the executive vice president now directly owns 34,798 shares of the company’s stock, valued at approximately $4,540,443.04. The disclosure for this sale can be found here. Over the last three months, insiders have sold 52,087 shares of company stock valued at $6,730,198. 0.78% of the stock is currently owned by insiders.

VAR opened at $137.78 on Friday. The company has a market cap of $12.40 billion, a P/E ratio of 31.17, a price-to-earnings-growth ratio of 3.63 and a beta of 0.85. Varian Medical Systems, Inc. has a fifty-two week low of $101.42 and a fifty-two week high of $138.35.

Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings results on Wednesday, January 23rd. The medical equipment provider reported $1.06 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.07 by ($0.01). The business had revenue of $741.00 million for the quarter, compared to the consensus estimate of $717.83 million. Varian Medical Systems had a return on equity of 26.18% and a net margin of 12.28%. The company’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period last year, the firm earned $1.06 earnings per share. On average, analysts predict that Varian Medical Systems, Inc. will post 4.7 EPS for the current year.

VAR has been the subject of a number of research analyst reports. Citigroup dropped their target price on shares of Varian Medical Systems from $145.00 to $131.00 and set a “buy” rating for the company in a research note on Wednesday, January 2nd. UBS Group started coverage on shares of Varian Medical Systems in a research note on Wednesday, November 28th. They issued a “buy” rating and a $140.00 target price for the company. Goldman Sachs Group raised shares of Varian Medical Systems from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $107.00 to $129.00 in a research note on Friday, January 4th. Jefferies Financial Group boosted their price target on shares of Varian Medical Systems to $145.00 and gave the stock a “buy” rating in a research note on Thursday, January 24th. Finally, Royal Bank of Canada boosted their price target on shares of Varian Medical Systems to $130.00 and gave the stock a “sector perform” rating in a research note on Thursday, January 24th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $130.63.

TRADEMARK VIOLATION NOTICE: This article was posted by Ticker Report and is the property of of Ticker Report. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.tickerreport.com/banking-finance/4239614/varian-medical-systems-inc-var-shares-sold-by-ancora-advisors-llc.html.

Varian Medical Systems Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.

See Also: What is Cost of Capital?

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Waves Community Token Trading 1.3% Higher  Over Last Week
Waves Community Token Trading 1.3% Higher Over Last Week
Telcoin Price Tops $0.0006 on Major Exchanges
Telcoin Price Tops $0.0006 on Major Exchanges
Crystal Clear  Market Capitalization Tops $26,650.00
Crystal Clear Market Capitalization Tops $26,650.00
SwissBorg  Market Cap Tops $5.04 Million
SwissBorg Market Cap Tops $5.04 Million
OAX Price Hits $0.23 on Major Exchanges
OAX Price Hits $0.23 on Major Exchanges
Haven Protocol Price Tops $0.44 on Top Exchanges
Haven Protocol Price Tops $0.44 on Top Exchanges


© 2006-2019 Ticker Report